Virtus LifeSci Biotech Products ETF
17 hedge funds and large institutions have $4.63M invested in Virtus LifeSci Biotech Products ETF in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$440K | |
| 2 | +$26.3K | |
| 3 | +$6.85K | |
| 4 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$2.27K |
| 5 |
MCC
Money Concepts Capital
Palm Beach Gardens,
Florida
|
+$2.12K |
Top Sellers
| 1 | -$164K | |
| 2 | -$56.9K | |
| 3 | -$32K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$28.8K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$4.93K |